Abstract
Panacos Pharmaceuticals Inc is developing the HIV Gag protein and viral maturation inhibitor bevirimat for the potential oral treatment of HIV infection. Phase II clinical trials are underway and phase III trials expected to commence in 2007.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 759-765 |
| Number of pages | 7 |
| Journal | Current Opinion in Investigational Drugs |
| Volume | 7 |
| Issue number | 8 |
| State | Published - Aug 1 2006 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery